University of Cambridge > Talks.cam > Cancer Research UK Cambridge Institute (CRUK CI) Seminars in Cancer > New Roles for Lysine Methylation Signaling in Epigenetic and Cancer Regulation

New Roles for Lysine Methylation Signaling in Epigenetic and Cancer Regulation

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Neil Bennett.

The main focus of the Gozani laboratory is to understand the molecular mechanisms by which protein lysine methylation regulates chromatin biology, epigenetics, and cellular signaling, and how disruption in these mechanisms contribute to cancer and other diseases. We study how lysine methylation events on histone and non-histone proteins are generated, sensed, and transduced, and how these chemical marks integrate with other modification and cellular signaling networks to govern diverse functions. We previously identified the PHD finger and the BAH domain as methyl lysine-binding “reader” domains and provided evidence that disrupting the read-out of histone modifications can cause inherited human diseases. Current research efforts are aimed at discovery and characterization of new methyl-sensitive reader domains functioning in both chromatin and non-chromatin pathways. Another major focus of the lab is to develop and apply proteomic strategies to uncover the catalytic and biological functions of the many orphan or poorly characterized protein lysine methyltransferases present in the human genome. I will discuss our most recent work in these areas with a focus on two enzymes implicated in tumorigenesis.

This talk is part of the Cancer Research UK Cambridge Institute (CRUK CI) Seminars in Cancer series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2020 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity